2-210591913-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001875.5(CPS1):​c.1030A>T​(p.Thr344Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,611,196 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T344A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 59 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.266

Publications

47 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035771728).
BP6
Variant 2-210591913-A-T is Benign according to our data. Variant chr2-210591913-A-T is described in ClinVar as Benign. ClinVar VariationId is 281331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0523 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.1030A>Tp.Thr344Ser
missense
Exon 10 of 38NP_001866.2
CPS1
NM_001369256.1
c.1063A>Tp.Thr355Ser
missense
Exon 11 of 39NP_001356185.1
CPS1
NM_001122633.3
c.1030A>Tp.Thr344Ser
missense
Exon 11 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.1030A>Tp.Thr344Ser
missense
Exon 10 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.1048A>Tp.Thr350Ser
missense
Exon 11 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000881564.1
c.1030A>Tp.Thr344Ser
missense
Exon 10 of 38ENSP00000551623.1

Frequencies

GnomAD3 genomes
AF:
0.0139
AC:
2108
AN:
151268
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00534
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000310
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00372
AC:
929
AN:
249584
AF XY:
0.00293
show subpopulations
Gnomad AFR exome
AF:
0.0503
Gnomad AMR exome
AF:
0.00213
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000257
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00156
AC:
2281
AN:
1459812
Hom.:
59
Cov.:
43
AF XY:
0.00133
AC XY:
966
AN XY:
726220
show subpopulations
African (AFR)
AF:
0.0544
AC:
1815
AN:
33366
American (AMR)
AF:
0.00251
AC:
112
AN:
44550
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86202
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53250
Middle Eastern (MID)
AF:
0.00487
AC:
28
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000909
AC:
101
AN:
1110746
Other (OTH)
AF:
0.00349
AC:
210
AN:
60232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
112
224
335
447
559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0139
AC:
2111
AN:
151384
Hom.:
46
Cov.:
32
AF XY:
0.0139
AC XY:
1026
AN XY:
73926
show subpopulations
African (AFR)
AF:
0.0482
AC:
1989
AN:
41290
American (AMR)
AF:
0.00533
AC:
81
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5114
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10470
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.000310
AC:
21
AN:
67734
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
104
209
313
418
522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000417
Hom.:
66075
ExAC
AF:
0.00438
AC:
531
EpiCase
AF:
0.000382
EpiControl
AF:
0.000535

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Congenital hyperammonemia, type I (3)
-
-
2
not specified (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
0.052
DANN
Benign
0.74
DEOGEN2
Uncertain
0.58
D
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.080
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
-0.33
N
PhyloP100
0.27
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.30
Sift
Benign
0.59
T
Sift4G
Benign
0.69
T
Polyphen
0.0010
B
Vest4
0.16
MutPred
0.23
Loss of sheet (P = 0.0817)
MVP
0.65
MPC
0.20
ClinPred
0.0021
T
GERP RS
-0.92
Varity_R
0.17
gMVP
0.22
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047883; hg19: chr2-211456637; API